Antiretroviral combination therapy

5 marketed 3 in Phase 3 1 in Phase 2

This page covers all Antiretroviral combination therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV reverse transcriptase, HIV protease, HIV integrase (depending on regimen composition), HIV reverse transcriptase, HIV protease (depending on formulation).

Targets

HIV reverse transcriptase, HIV protease, HIV integrase (depending on regimen composition) · HIV reverse transcriptase, HIV protease (depending on formulation)

Marketed (5)

Phase 3 pipeline (3)

Phase 2 pipeline (1)